NextCure, Inc.NXTCNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank63
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-0.72
↑ 93% vs avg
Percentile
P63
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-9.78
Historical baseline
PeriodValueYoY Change
2025-0.72-86.5%
2024-0.39+23.4%
2023-0.51+3.3%
2022-0.52+78.1%
2021-2.39+70.9%
2020-8.20+68.7%
2019-26.21-32.2%
2018-19.83+32.2%
2017-29.22-